Management of Acute Severe Hypertension with Intravenous Nicardipine

Primary Indications for IV Nicardipine

• The European Society of Cardiology recommends administering nicardipine IV when severe hypertension (>180/120 mmHg) is accompanied by acute target organ damage, including hypertensive encephalopathy, acute stroke, acute coronary syndrome, acute heart failure, or aortic dissection 1, 2
• The American Heart Association suggests that nicardipine is a first-line intravenous agent alongside labetalol and clevidipine for most hypertensive emergencies requiring immediate blood pressure control, as per the guidelines from the Stroke journal 3

Acute Ischemic Stroke Management

• The American Heart Association recommends using nicardipine when blood pressure exceeds 185/110 mmHg in patients being considered for thrombolytic therapy, as stated in the Stroke journal guidelines 3, 6
• The American Stroke Association suggests that after thrombolysis or mechanical thrombectomy, nicardipine maintains blood pressure below 180/105 mmHg to reduce hemorrhagic transformation risk, according to the Stroke journal guidelines 3, 6

Dosing Algorithm

• The European Society of Cardiology recommends starting at 5 mg/hr continuous IV infusion, with an onset of action occurring within 5-15 minutes 1
• The European Society of Cardiology suggests that the maximum dose is 15 mg/hr, and the duration of action is 30-40 minutes after discontinuation 1

Blood Pressure Reduction Targets

• The American College of Cardiology recommends reducing systolic blood pressure by no more than 25% within the first hour, as per the guidelines from the Praxis Medical Insights 4, 5

Critical Contraindications and Precautions

• The European Society of Cardiology states that liver failure is listed as a contraindication due to hepatic metabolism 1
• The European Society of Cardiology recommends changing the infusion site every 12 hours when using peripheral veins to minimize risk of phlebitis and venous thrombosis 1

Monitoring Requirements

• The American Heart Association suggests monitoring blood pressure and heart rate continuously during infusion, and checking blood pressure every 15 minutes for 2 hours, then every 30 minutes for 6 hours, then hourly for 16 hours in stroke patients receiving thrombolytics, as per the Stroke journal guidelines 3, 6